文献速递糖尿病肥胖与代谢综合征性腺与生殖内分泌

绝经:心血管代谢的转折点

Menopause: a cardiometabolic transition.
PubMed 文献 · Lancet Diabetes Endocrinol · 2022-05-04

绝经常是女性健康的转折点,实验与临床研究表明心血管代谢改变在绝经过渡期显现,将衰老效应叠加于心血管疾病风险之上。绝经过渡期与脂肪量增加(主要位于躯干区)、胰岛素抵抗增加、血脂异常及内皮功能障碍相关。本文为两篇系列综述中的第一篇,概述中年(40-65岁)高危女性的心血管代谢改变与管理,聚焦可预测心血管疾病发生的因素,并总结心血管代谢健康背景下的非激素预防策略证据。

要点

  • 绝经过渡期与脂肪量增加(主要位于躯干区)、胰岛素抵抗增加、血脂异常及内皮功能障碍相关。
  • 生育期内源性雌激素暴露提供心血管疾病保护,该保护在绝经开始约10年后丧失。
  • 有血管舒缩症状的绝经女性似乎心血管代谢特征不良。

核心结论

  • 绝经过渡期的心血管代谢改变将衰老效应叠加于心血管疾病风险之上。
  • 早期管理心血管疾病传统危险因素至关重要。
  • 识别生殖史中的女性特有状况可增强绝经过渡期及之后的心血管疾病风险。

研究设计与样本

  • 本文为两篇系列综述中的第一篇,基于文献概述中年(40-65岁)高危女性的心血管代谢改变与管理。

主要发现

  • 绝经过渡期与脂肪量增加(主要位于躯干区)、胰岛素抵抗增加、血脂异常及内皮功能障碍相关。
  • 生育期内源性雌激素提供心血管疾病保护,该保护在绝经开始约10年后丧失。
  • 有血管舒缩症状的绝经女性似乎心血管代谢特征不良。

关键数值与推荐

  • 早期管理传统心血管疾病危险因素(即高血压、肥胖、糖尿病、血脂异常和吸烟)至关重要。
  • 识别生殖史中可增强绝经过渡期及之后心血管疾病风险的女性特有状况(即妊娠期高血压或糖尿病、早发性卵巢功能不全、某些妇科疾病如功能性下丘脑性闭经,可能还有其他状况)。

临床怎么用

  • 早期管理传统心血管疾病危险因素(即高血压、肥胖、糖尿病、血脂异常和吸烟)至关重要。
  • 识别生殖史中可增强绝经过渡期及之后心血管疾病风险的女性特有状况(即妊娠期高血压或糖尿病、早发性卵巢功能不全、某些妇科疾病如功能性下丘脑性闭经,可能还有其他状况)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Menopause is often a turning point for women's health worldwide. Increasing knowledge from experimental data and clinical studies indicates that cardiometabolic changes can manifest at the menopausal transition, superimposing the effect of ageing onto the risk of cardiovascular disease. The menopausal transition is associated with an increase in fat mass (predominantly in the truncal region), an increase in insulin resistance, dyslipidaemia, and endothelial dysfunction. Exposure to endogenous oestrogen during the reproductive years provides women with protection against cardiovascular disease, which is lost around 10 years after the onset of menopause. In particular, women with vasomotor symptoms during menopause seem to have an unfavourable cardiometabolic profile. Early management of the traditional risk factors of cardiovascular disease (ie, hypertension, obesity, diabetes, dyslipidaemia, and smoking) is essential; however, it is important to recognise in the reproductive history the female-specific conditions (ie, gestational hypertension or diabetes, premature ovarian insufficiency, some gynaecological diseases such as functional hypothalamic amenorrhoea, and probably others) that could enhance the risk of cardiovascular disease during and after the menopausal transition. In this Review, the first of a Series of two papers, we provide an overview of the literature for understanding cardiometabolic changes and the management of women at midlife (40-65 years) who are at higher risk, focusing on the identification of factors that can predict the occurrence of cardiovascular disease. We also summarise evidence about preventive non-hormonal strategies in the context of cardiometabolic health.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Nappi RE, Chedraui P, Lambrinoudaki I, et al. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022. PMID: 35525259. doi:10.1016/S2213-8587(22)00076-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。